Press Release New Operation HOPE Research Finds That Financial Literacy Resources, Tools & Coaching Services Are Key Drivers of Optimism Despite Uncertain Economic Times 11 December 2023
Press Release Long-term ALPHA Phase III trial data showed danicopan as add-on to ULTOMIRIS® or SOLIRIS® sustained clinical improvements in subset of patients with PNH experiencing clinically significant extravascular hemolysis 11 December 2023
Press Release MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study 11 December 2023
Press Release Latest Data of InnoCare’s Oncology Pipelines Presented at the 65th Annual Meeting of ASH 11 December 2023
Press Release New Data for Genentech’s Columvi and Lunsumio Presented at ASH 2023 Support Continued Benefit for People With Lymphoma 11 December 2023
Press Release ADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy Combination Delivers 100% Progression Free Survival at 12 months in Phase 2 Trial of Patients with Early Stage Classical Hodgkin Lymphoma 11 December 2023
Press Release VINSSEN Co., Ltd. Successfully Supplies Hydrogen Fuel Cell for Industry Project in Singapore 11 December 2023
Press Release FCA-Authorised Digital Asset Derivatives Venue GFO-X Raises $30m Series B Funding, Led by M&G Investments 11 December 2023
Press Release Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Durable Responses in Chronic Graft-Versus-Host Disease 10 December 2023
Press Release Morrow Sodali Acquires Australian Corporate Communication Consultancy, Domestique 10 December 2023
